Adamas Nanotechnologies, Inc.
- UEI
- XV1FPSTT7LF4
- CAGE
- 6TKC2
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
-
- 541713 Research and Development in Nanotechnology Primary
- 325998 All Other Miscellaneous Chemical Product and Preparation Manufacturing
- 327910 Abrasive Product Manufacturing
- 541690 Other Scientific and Technical Consulting Services
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration date
- Website
- adamasnano.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Information Technology
- Technology Hardware & Equipment
- Electronic Equipment, Instruments & Components
- Nanotechnology
- SIC code
- 87 Engineering & Management Services
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Real-time measurement of mitochondrial temperature with fluorescent nanodiamond - summary mitochondria are critically… | National Institute of General Medical Sciences | $306,872 | |
| Advancing nanodiamond particles for quantum sensing - summary single-molecule fluorescent live-cell imaging impacts… | National Institute of General Medical Sciences | $618,354 | |
| Sbir, phase i (R43): ultrasensitive lateral flow assays enabled by fluorescent nanodiamond labels | Office of Financial Resources | $300,583 | |
| Photo-hyperpolarized 13C MRI - summary. High resolution imaging in deep tissue (> 1 CM) environments can address a… | National Institute of General Medical Sciences | $2,493,507 | |
| Atmospheric pressure plasma functionalization of nanodiamond particles | Office of Science | $195,998 |
About Adamas Nanotechnologies, Inc.
Adamas Nanotechnologies, Inc., a for-profit manufacturer of nanodiamond-based quantum sensing materials, operates as a prime recipient on federal research grants focused on fluorescent nanodiamond development and biomedical imaging applications, with no federal contract prime or subcontractor work in the recent award footprint. The Raleigh, North Carolina–based company competes exclusively in full-and-open federal research funding, not set-asides, and holds no SBA certifications or minority-ownership designations.
Adamas's federal grant portfolio centers on the development and commercialization of nitrogen-vacancy (NV) center–hosting nanodiamonds for quantum sensing and biomedical measurement applications. The company's capability work includes development of real-time mitochondrial temperature monitoring using fluorescent nanodiamonds with NV centers (a $306,872 Phase I award from the National Institute of General Medical Sciences under CFDA 93.859, effective July 1, 2026 through June 30, 2028); quantum sensors for free radical detection in whole blood (a Phase II SBIR running through July 31, 2027 from the National Center for Advancing Translational Sciences); photo-hyperpolarized 13C MRI probes for deep-tissue imaging (a project grant from the Department of Energy Office of Science running through July 31, 2027); and ultrasmall nanodiamond particles with stabilized NV centers for quantum sensing (a Phase I SBIR from NIGMS awarded June 7, 2024, with a Technical and Business Assistance supplement focused on commercialization and customer engagement). The company has also performed feasibility research on ultrasensitive lateral flow assays enabled by fluorescent nanodiamond labels and developed precision scanning microscopy diamond probes. Adamas's research spans optical NMR, atmospheric-pressure plasma surface functionalization of nanodiamonds, and color-center-hosting diamond probes for cellular-level imaging.
Customer concentration is heavily weighted to the National Institutes of Health (HHS-NIH) and the Department of Energy. The National Institute of General Medical Sciences (HHS-NIH-NIGMS) accounts for four awards, while the National Heart Lung and Blood Institute (HHS-NIH-NHLBI) accounts for three awards carrying $1.7 million in combined potential value. The Department of Energy Office of Science holds three awards. The Centers for Disease Control and Prevention (HHS-CDC) and the National Cancer Institute (HHS-NIH-NCI) round out a six-agency customer base covering 92% of recent awards. Award activity shows episodic distribution — two awards in 2018, two in 2021, five in 2022, one in 2024, and one in 2026 — with three awards reaching ultimate completion within the next twenty-four months. The vendor's total combined potential value across all thirteen awards stands at $1.7 million, though obligated dollars across the portfolio total $11.9 million, indicating substantial invoicing against awards whose original potential values have been exceeded through scope expansions or repricing.
Quick answers
What is Adamas Nanotechnologies, Inc.'s UEI?
Adamas Nanotechnologies, Inc.'s Unique Entity ID (UEI) in SAM.gov is XV1FPSTT7LF4.
What is Adamas Nanotechnologies, Inc.'s CAGE code?
Adamas Nanotechnologies, Inc.'s CAGE code is 6TKC2.
What is Adamas Nanotechnologies, Inc.'s primary NAICS code?
Adamas Nanotechnologies, Inc.'s primary NAICS code is 541713 (Research and Development in Nanotechnology).
Is Adamas Nanotechnologies, Inc. registered in SAM.gov?
Adamas Nanotechnologies, Inc.'s SAM.gov registration expired on October 6, 2026.
What is Adamas Nanotechnologies, Inc.'s most recent federal award?
Adamas Nanotechnologies, Inc.'s most recent federal grant award is Real-time measurement of mitochondrial temperature with fluorescent nanodiamond - summary mitochondria are critically… (R43GM165231), from National Institute of General Medical Sciences, on July 1, 2026.
On GovTribe
See Adamas Nanotechnologies, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors